{"filing":{"accession_number":"0001493152-26-029599","cik":"0001847345","ticker":"ASBPW","company_name":"Aspire Biopharma Holdings, Inc.","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/form8-k.htm"},"events":[{"id":12816,"run_id":11374,"accession_number":"0001493152-26-029599","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses results of a Special Meeting of Stockholders held on June 16, 2026, where shareholders voted on and approved three warrant-related proposals: authorization of warrant share issuance (including shares exceeding 19.99% of outstanding common stock), adjustment of shares issuable upon warrant exercise, and adjustment of warrant exercise prices. The vote tallies are provided for each proposal, directly matching Item 5.07 disclosure requirements for shareholder vote results.","company_name":"Aspire Biopharma Holdings, Inc.","ticker":"ASBPW","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":9778,"accession_number":"0001493152-26-029599","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses results of a Special Meeting of Stockholders held on June 16, 2026, where shareholders voted on and approved three warrant-related proposals: authorization of warrant share issuance (including shares exceeding 19.99% of outstanding common stock), adjustment of shares issuable upon warrant exercise, and adjustment of warrant exercise prices. The vote tallies are provided for each proposal, directly matching Item 5.07 disclosure requirements for shareholder vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:54:54.323336+00:00","company_name":"Aspire Biopharma Holdings, Inc.","ticker":"ASBPW","filing_date":"2026-06-22"}]}